BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 15 analysts with an average price target of $58.58. This is a potential upside of $26.18 (80.8%) from yesterday's end of day stock price of $32.4.

Beam Therapeutics 's activity chart (see below) currently has 46 price targets and 68 ratings on display. The stock rating distribution of BEAM is 36.84% HOLD and 63.16% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.7% with an average time for these price targets to be met of 72.14 days.

Highest price target for BEAM is $80, Lowest price target is $24, average price target is $58.58.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 03-Feb-2025. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 14 are a HOLD (36.84%), 24 are a BUY (63.16%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$47.6 (146.91%)

$80

12 days ago
(03-Feb-2025)

0/5 (0%)

$54.41 (212.62%)

Buy

$39

17 days ago
(29-Jan-2025)

1/10 (10%)

$12.38 (46.51%)

118

3 months 9 days ago
(06-Nov-2024)

0/2 (0%)

$32.61 (73.46%)

Hold

$24

$-8.4 (-25.93%)

$27

3 months 9 days ago
(06-Nov-2024)

6/6 (100%)

$-2.62 (-9.84%)

72

Hold

$24

$-8.4 (-25.93%)

$35

3 months 30 days ago
(16-Oct-2024)

2/4 (50%)

$-2.69 (-10.08%)

38

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 72.14 days on average for the stock forecasts to be realized with a an average price target met ratio 37.7

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 7 price targets and 4 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Yanan Zhu with highest potential upside - $72.6

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Greg Harrison with lowest potential downside - -$8.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?